Teladoc Health Inc. (TDOC)
NYSE: TDOC
· Real-Time Price · USD
7.50
0.20 (2.74%)
At close: Aug 15, 2025, 12:42 PM
Teladoc Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.54B | 2.55B | 2.57B | 2.59B | 2.61B | 2.62B | 2.6B | 2.58B | 2.53B | 2.47B | 2.41B | 2.32B | 2.23B | 2.14B | 2.03B | 1.86B | 1.63B | 1.37B |
Cost of Revenue | 756.04M | 850.13M | 945.73M | 950.22M | 956.44M | 862.35M | 760.03M | 755.48M | 755.14M | 747.07M | 743.99M | 730.1M | 713.52M | 691.32M | 650.26M | 598.22M | 533.9M | 464.41M |
Gross Profit | 1.79B | 1.7B | 1.62B | 1.64B | 1.65B | 1.76B | 1.84B | 1.82B | 1.78B | 1.72B | 1.66B | 1.59B | 1.52B | 1.45B | 1.38B | 1.26B | 1.1B | 902.43M |
Operating Income | -267.61M | -262.42M | -218.88M | -257.8M | -278.13M | -276.62M | -248.55M | 3.59B | 3.58B | 3.57B | 3.55B | -235.94M | -226.38M | -241.67M | -261.48M | -682.71M | -641.86M | -570.09M |
Interest Income | 32.17M | 55.8M | 57.07M | 56.55M | 53.83M | 51.81M | 46.78M | 34.97M | 27.16M | 16.83M | 7.92M | 6.03M | 1.23M | n/a | n/a | n/a | 252K | 252K |
Pretax Income | -232.36M | -1.03B | -993.65M | -970.86M | -997.92M | -230.26M | -219.61M | -4.01B | -4.02B | -7.06B | -13.66B | -9.91B | -9.92B | -6.95B | -384.66M | -803.35M | -760.83M | -658.29M |
Net Income | -207.36M | -1.01B | -1B | -981.73M | -1.01B | -233.03M | -220.37M | -4B | -4.02B | -7.05B | -13.66B | -9.86B | -9.87B | -6.9B | -428.79M | -811.77M | -763.32M | -655.18M |
Selling & General & Admin | 1.27B | 1.33B | 1.35B | 1.17B | 1.13B | 1.16B | 1.15B | 1.33B | 1.37B | 1.35B | 1.3B | 1.27B | 1.2B | 1.14B | 1.11B | 1.35B | 1.2B | 1.05B |
Research & Development | 287.88M | 295.84M | 307.27M | 320.46M | 332.37M | 342.92M | 348.52M | 341.51M | 345.04M | 338.56M | 338.98M | 328.92M | 321.36M | 321.29M | 311.88M | 331.71M | 281.42M | 223.69M |
Other Expenses | 595.45M | 443.58M | 240.98M | 92.68M | -2.73M | 73.3M | 143.46M | 219.17M | 282.97M | 266.88M | 256.03M | 232.64M | 222.54M | 214.51M | 204.24M | 188.87M | 149.89M | 108.44M |
Operating Expenses | 2.05B | 1.97B | 1.84B | 1.58B | 1.46B | 1.58B | 1.65B | 1.89B | 2B | 1.95B | 1.89B | 1.83B | 1.74B | 1.68B | 1.62B | 1.87B | 1.64B | 1.38B |
Interest Expense | 22.74M | 23.92M | 23.8M | 22.5M | 22.48M | 22.67M | 22.28M | 16.74M | 17.25M | 16.97M | 17.19M | 36.06M | 48.81M | 63.72M | 80.36M | 82.31M | 80.64M | 73.43M |
Selling & Marketing Expenses | 836.8M | 889.97M | 910.78M | 736.34M | 697.56M | 695.27M | 688.85M | 838.57M | 885.97M | 890.06M | 850.71M | 820.3M | 760.43M | 705M | 667.31M | 682.68M | 584.79M | 483.98M |
Cost & Expenses | 2.81B | 2.82B | 2.79B | 2.53B | 2.42B | 2.44B | 2.41B | 2.65B | 2.76B | 2.7B | 2.64B | 2.56B | 2.46B | 2.37B | 2.27B | 2.46B | 2.17B | 1.85B |
Income Tax Expense | -25M | -13.35M | 7.59M | 10.87M | 7.61M | 2.77M | 760K | -4.59M | -3.28M | -3.52M | -3.81M | -51.71M | -46.9M | -42.51M | 44.14M | 8.42M | 2.49M | -3.11M |
Shares Outstanding (Basic) | 175.92M | 174.15M | 172.76M | 170.23M | 170.23M | 167.73M | 166.06M | 165.12M | 164.17M | 162.92M | 162.17M | 161.73M | 161.38M | 160.53M | 159.94M | 159.44M | 156.06M | 152.17M |
Shares Outstanding (Diluted) | 175.92M | 174.15M | 172.76M | 171.5M | 170.23M | 167.73M | 166.06M | 165.12M | 164.17M | 162.92M | 162.17M | 161.73M | 161.38M | 160.53M | 159.94M | 159.44M | 156.06M | 152.17M |
EPS (Basic) | -1.2 | -5.93 | -5.89 | -5.78 | -5.93 | -1.41 | -1.34 | -24.66 | -24.76 | -43.58 | -84.74 | -61.32 | -61.4 | -43.04 | -2.77 | -5.77 | -5.67 | -5.15 |
EPS (Diluted) | -1.19 | -5.92 | -5.88 | -5.77 | -5.93 | -1.41 | -1.34 | -24.66 | -24.76 | -43.58 | -84.74 | -61.32 | -61.4 | -43.04 | -2.77 | -5.77 | -5.67 | -5.15 |
EBITDA | -59.67M | -734.57M | -587.01M | -555.71M | -580.29M | 164.16M | 142.18M | -3.67B | -3.72B | -6.77B | -6.78B | -3.03B | -3.04B | -57.66M | -87.62M | -524.44M | -523.28M | -472.44M |
EBIT | -209.61M | -1B | -969.85M | -948.36M | -975.44M | -207.59M | -202.59M | -4B | -4.01B | -7.05B | -7.04B | -3.27B | -3.27B | -278.68M | -304.29M | -721.04M | -680.44M | -585.11M |
Depreciation & Amortization | 168.38M | 267.23M | 382.84M | 392.65M | 398.33M | 378.99M | 352M | 329.4M | 297.34M | 281.29M | 270.64M | 248.79M | 238.43M | 230.89M | 218.39M | 201.41M | 161.72M | 117.23M |